Conference Coverage

VIDEO: Advanced practice providers take on many roles in MS care


 

REPORTING FROM ACTRIMS FORUM 2018

– A new survey suggests that advanced practice providers who care for multiple sclerosis patients are highly satisfied with their jobs, which encompass a wide range of responsibilities.

Researchers received survey responses from 215 nurse practitioners and 395 physician assistants who answered Web questionnaires in 2016 and 2017. Of those who care for multiple sclerosis (MS) patients, 92.5% and 77.8% respectively said they provide at least 9 of 11 services, such as direct care, supportive services, and care coordination.

“Nurse practitioners in particular are providing lots of different services from diagnosis to education to symptom management,” said Michael T. Halpern, MD, PhD, MPH, of Temple University, Philadelphia. “Physician assistants are also providing a diverse range of MS services, but not as frequently as nurse practitioners.”

Dr. Halpern was the presenting author of the study reporting the survey results. He spoke in a video interview at ACTRIMS Forum 2018, held by the Americas Committee for Treatment and Research in Multiple Sclerosis, where the study findings were presented.

Advanced practice providers also reported high levels of job satisfaction. About 80% in both groups reported being very or extremely satisfied with their careers and with their colleagues; 90% of nurse practitioners reported being very or extremely satisfied by their relationships with patients, as did 86% of physician assistants.


The providers “appear to really enjoy working with individuals with MS,” Dr. Halpern said. But he cautioned that there’s a need for additional training for these providers; some respondents said their lack of knowledge was a hindrance to care.

The study was funded by the National Multiple Sclerosis Society. Dr. Halpern reported no relevant disclosures.

Recommended Reading

VIDEO: Efficacy of DMTs decreases with age
MDedge Neurology
VIDEO: Oral ozanimod shows promise for relapsing MS
MDedge Neurology
Switching RRMS patients to daclizumab beta appears safe
MDedge Neurology
Third course of alemtuzumab can improve MS outcomes
MDedge Neurology
VIDEO: Managing the alemtuzumab paradox
MDedge Neurology
MS: Past, Present, and Future
MDedge Neurology
Rituximab May Provide Greater Benefits Than Other First-Line MS Therapies
MDedge Neurology
MAGNIMS and McDonald Criteria Have Similar Accuracy
MDedge Neurology
Trial of clozapine, risperidone halted in MS
MDedge Neurology
‘Real-world evidence’ used to compare agents for relapsing-remitting MS
MDedge Neurology